Clinical Trial Update: A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial evaluated bevacizumab in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine glioma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• High-grade Glioma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Newly Diagnosed High-Grade Gliomas, Diffuse Intrinsic Pontine Glioma | EARLY_Phase 1 | Status: COMPLETED